These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8768767)

  • 1. Molecular diversity in chemical databases: comparison of medicinal chemistry knowledge bases and databases of commercially available compounds.
    Cummins DJ; Andrews CW; Bentley JA; Cory M
    J Chem Inf Comput Sci; 1996; 36(4):750-63. PubMed ID: 8768767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the diversity represented in commercially-available databases.
    Bradley MP
    Mol Divers; 2002; 5(4):175-83. PubMed ID: 12549670
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing the scaffold diversity of screening libraries.
    Krier M; Bret G; Rognan D
    J Chem Inf Model; 2006; 46(2):512-24. PubMed ID: 16562979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leadlikeness and structural diversity of synthetic screening libraries.
    Verheij HJ
    Mol Divers; 2006 Aug; 10(3):377-88. PubMed ID: 17031539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical similarity searches using latent semantic structural indexing (LaSSI) and comparison to TOPOSIM.
    Hull RD; Fluder EM; Singh SB; Nachbar RB; Kearsley SK; Sheridan RP
    J Med Chem; 2001 Apr; 44(8):1185-91. PubMed ID: 11312918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large descriptor set and a probabilistic kernel-based classifier significantly improve druglikeness classification.
    Li Q; Bender A; Pei J; Lai L
    J Chem Inf Model; 2007; 47(5):1776-86. PubMed ID: 17718552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Property distribution of drug-related chemical databases.
    Oprea TI
    J Comput Aided Mol Des; 2000 Mar; 14(3):251-64. PubMed ID: 10756480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-likeness and increased hydrophobicity of commercially available compound libraries for drug screening.
    Zuegg J; Cooper MA
    Curr Top Med Chem; 2012; 12(14):1500-13. PubMed ID: 22827520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using novel descriptor accounting for ligand-receptor interactions to define and visually explore biologically relevant chemical space.
    Rabal O; Oyarzabal J
    J Chem Inf Model; 2012 May; 52(5):1086-102. PubMed ID: 22486368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the relationship between topology and selectivity for druglike molecules.
    Yang Y; Chen H; Nilsson I; Muresan S; Engkvist O
    J Med Chem; 2010 Nov; 53(21):7709-14. PubMed ID: 20942392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward automated biochemotype annotation for large compound libraries.
    Chen X; Liang Y; Xu J
    Mol Divers; 2006 Aug; 10(3):495-509. PubMed ID: 16967195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple method to improve the odds in finding 'lead-like' compounds from chemical libraries.
    Horio K; Muta H; Goto J; Hirayama N
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):980-4. PubMed ID: 17603185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexophore, a new versatile 3D pharmacophore descriptor that considers molecular flexibility.
    von Korff M; Freyss J; Sander T
    J Chem Inf Model; 2008 Apr; 48(4):797-810. PubMed ID: 18393490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LASSOO: a generalized directed diversity approach to the design and enrichment of chemical libraries.
    Koehler RT; Dixon SL; Villar HO
    J Med Chem; 1999 Nov; 42(22):4695-704. PubMed ID: 10579831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of chemical libraries for their druggability.
    Sirois S; Hatzakis G; Wei D; Du Q; Chou KC
    Comput Biol Chem; 2005 Feb; 29(1):55-67. PubMed ID: 15680586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical information based scaling of molecular descriptors: a universal chemical scale for library design and analysis.
    Tounge BA; Pfahler LB; Reynolds CH
    J Chem Inf Comput Sci; 2002; 42(4):879-84. PubMed ID: 12132889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scoring scheme for discriminating between drugs and nondrugs.
    Sadowski J; Kubinyi H
    J Med Chem; 1998 Aug; 41(18):3325-9. PubMed ID: 9719584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The scaffold tree: an efficient navigation in the scaffold universe.
    Ertl P; Schuffenhauer A; Renner S
    Methods Mol Biol; 2011; 672():245-60. PubMed ID: 20838972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.